Minthon L - Search Results

1

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.

Sjögren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A. Sjögren M, et al. Among authors: minthon l. Neurology. 2000 May 23;54(10):1960-4. doi: 10.1212/wnl.54.10.1960. Neurology. 2000. PMID: 10822437

2

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K. Olsson A, et al. Among authors: minthon l. Exp Neurol. 2003 Sep;183(1):74-80. doi: 10.1016/s0014-4886(03)00027-x. Exp Neurol. 2003. PMID: 12957490 Clinical Trial.

3

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

Rüetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K. Rüetschi U, et al. Among authors: minthon l. Exp Neurol. 2005 Dec;196(2):273-81. doi: 10.1016/j.expneurol.2005.08.002. Epub 2005 Sep 8. Exp Neurol. 2005. PMID: 16154129

4

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.

Sjögren M, Minthon L, Passant U, Blennow K, Wallin A. Sjögren M, et al. Among authors: minthon l. Neurobiol Aging. 1998 Sep-Oct;19(5):379-84. doi: 10.1016/s0197-4580(98)00086-4. Neurobiol Aging. 1998. PMID: 9880039

5

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: minthon l. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

6

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K. Andreasen N, et al. Among authors: minthon l. Neurology. 1999 Oct 22;53(7):1488-94. doi: 10.1212/wnl.53.7.1488. Neurology. 1999. PMID: 10534256

7

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

Tarkowski E, Liljeroth AM, Nilsson A, Ricksten A, Davidsson P, Minthon L, Blennow K. Tarkowski E, et al. Among authors: minthon l. Neurology. 2000 Jun 13;54(11):2077-81. doi: 10.1212/wnl.54.11.2077. Neurology. 2000. PMID: 10851366

8

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.

Sjögren M, Minthon L, Davidsson P, Granérus A-K, Clarberg A, Vanderstichele H, Vanmechelen E, Wallin A, Blennow K. Sjögren M, et al. Among authors: minthon l. J Neural Transm (Vienna). 2000;107(5):563-79. doi: 10.1007/s007020070079. J Neural Transm (Vienna). 2000. PMID: 11072752

9

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K. Andreasen N, et al. Among authors: minthon l. Arch Neurol. 2001 Mar;58(3):373-9. doi: 10.1001/archneur.58.3.373. Arch Neurol. 2001. PMID: 11255440 Clinical Trial.

10

Both total and phosphorylated tau are increased in Alzheimer's disease.

Sjögren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C, Granérus AK, Vanderstichele H, Vanmechelen E, Blennow K. Sjögren M, et al. Among authors: minthon l. J Neurol Neurosurg Psychiatry. 2001 May;70(5):624-30. doi: 10.1136/jnnp.70.5.624. J Neurol Neurosurg Psychiatry. 2001. PMID: 11309456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters